S078 DTx series 5/5: Diabetes clinical trials on Whatsapp? (Abhishek Shah)

Wellthy is one of Asia’s leading digital therapeutics companies that inspires and enables patients to prevent, reverse and control chronic diseases. It works with pharmaceutical, medical devices companies, payors and healthcare providers to improve health outcomes. With active therapeutic areas in diabetes and cardiology, it has published real-world evidence across 20 publications in leading peer-reviewed journals and global conferences. In this episode, the last one of the 5-part series about digital therapeutics, Abhishek Shah, the CEO and Founder of Wellthy, on of the largest DTx companies in Asia, talks about the importance of understanding that healthcare is always local and shared some vivid examples of different rules of engagement with users in India compared to the West.
Recap: https://www.facesofdigitalhealth.com/blog/s078-dtx-series-55-chronic-disease-management-in-india-abhishek-shah
Wellthy: https://wellthytherapeutics.com/about


Registered Users

Please login or register to continue.